Skip to main content

Table 2 Comparison of quantitative PET/CT parameters between all groups

From: Role of PET/CT in initial evaluation of lymphoma patients

 

Partial response

Complete response

Stable disease

Progressive disease

P value

Baseline SUV

Median

12.6

9.7

3.4

2.7

P = 0.0004A

IQR

9–15.8

5.6–14

2.8–4.2

1.8–16.4

 

Range

3.1–29

1.3–25

2.5–4.6

1.8–16.4

 

Post-treatment SUV

Median

3.3

0

3

6.3

P < 0.000001B

IQR

2–4.8

0–0

2.4–3.7

2.7–22.1

 

Range

1.18–8.2

0–0

1.8–4.5

2.7–22.1

 

∆SUV (%)

Median

74.5

100

11.9

− 53.4

P < 0.000001

IQR

65.3–80.8

100–100

1.1–24.8

− 137.7 to 35.1

 

Range

41.9–87.3

100–100

0–28

− 137.7 to − 35.1

 

Baseline MTV

Median

29.8

5.8

42.5

31.2

P = 0.011C

IQR

4.8–78

2.8–23.1

6.9– 264.5

2.9–39

 

Range

1.13–215

1.13–182

2.8–455

2.9–39

 

Post-treatment MTV

Median

2.6

0

32.7

38.4

P < 0.000001D

IQR

1–6

0–0

6.3–238.2

5.1–47.7

 

Range

0.5–92

0–0

1.6–422

5.1–47.7

 

∆MTV (%)

Median

75.5

100

16.95

− 23.1

P < 0.000001

IQR

55.8–94.4

100–100

3.7–34.8

− 76.2 to − 22.4

 

Range

39.9–99.4

100–100

0–42.9

− 76.2 to − 22.4

 

Baseline TLG

Median

250

25

100

49.1

P = 0.037E

IQR

24.7–1081

11.3–173.7

13.5–685.5

4.7–306.5

 

Range

6.8–2038

2.6–1804

4–1194

4.7–306.5

 

Post-treatment TLG

Median

6.5

0

61

60.4

P < 0.000001F

IQR

2.3–15.3

0–0

12.4–564.5

17.1–528.2

 

Range

0.8–117.6

0–0

1.8–1030

17.1–528.2

 

∆TLG (%)

Median

91.4

100

28.9

− 65.5

P < 0.000001

IQR

85.6–99.2

100–100

6.9–49.6

− 263.8 to − 23

 

Range

71.2–99.9

100–100

0–55

263.8 to − 23